Muutke küpsiste eelistusi

Thinking About Prescribing: The Psychology of Psychopharmacology With Diverse Youth and Families [Pehme köide]

Edited by (Yale University), Edited by (Stanford University)
  • Formaat: Paperback / softback, 395 pages, kõrgus x laius x paksus: 229x152x17 mm, kaal: 630 g, 13 Figures; 21 Tables, unspecified
  • Ilmumisaeg: 19-Mar-2022
  • Kirjastus: American Psychiatric Association Publishing
  • ISBN-10: 1615373888
  • ISBN-13: 9781615373888
Teised raamatud teemal:
  • Formaat: Paperback / softback, 395 pages, kõrgus x laius x paksus: 229x152x17 mm, kaal: 630 g, 13 Figures; 21 Tables, unspecified
  • Ilmumisaeg: 19-Mar-2022
  • Kirjastus: American Psychiatric Association Publishing
  • ISBN-10: 1615373888
  • ISBN-13: 9781615373888
Teised raamatud teemal:
Our remedies are only as good as the way in which we dispense themThat's the central premise of Thinking About Prescribing, a new volume that encourages pharmacotherapists to view the prescribing of a psychiatric medication to young patients not simply as part of a clinical visit, but rather as the beginning of an ongoing alliance with youth and their parents or legal guardians.The book makes the case for a partnership that doesn't lean on psychiatric jargon or an encyclopedic list of side effects, but instead on measured candor, vulnerability, and—most importantly—time.Thinking About Prescribing leverages the knowledge of more than two dozen experts as it tackles topics that include: • The essential features of the Common Factors approach and the Y-model of psychotherapy, which highlights how relational aspects of pharmacotherapy are key to child & adolescent psychiatric practice, even for brief visits• How best to utilize the 30-minute Brief Pharmacotherapy Visit (BPV), so that the alliance is nurtured and time is most efficiently utilized• Techniques, adapted from evidence-based psychotherapies, to enhance medication adherence in diverse youth populations• Approaches to adapt psychoeducation for culturally diverse populations, and consider why many youth & families may be skeptical of pharmacotherapeutic interventions• Strategies to cultivate a pharmacotherapeutic alliance when engaging with patients and families via telehealth, including in the school setting• Tips for pediatricians, advanced-practice clinicians, and other primary care providers who conduct pharmacotherapy The chapters feature key takeaways that distill the most salient points and that aid in knowledge retention.Rather than raise unrealistic expectations (two chapters acknowledge the reality of practicing when time and resources are scarce), the goal of this book is to help pharmacotherapists mitigate the stigma, apprehension, or resignation their patients may have and instead build and maintain a trusting relationship that will be key to successful therapeutic outcomes.

""Our remedies are only as good as the way in which we dispense them." That is the central premise of Thinking About Prescribing. In this new, thought-provoking volume, more than two dozen experts make the case for an ongoing alliance between pharmacotherapists, young patients, and their families. Chapters tackle issues ranging from the psychodynamics of medication use in youth with serious mental illness, adapting evidence-based motivation and therapy techniques to enhance adherence, cultivating the synergistic role of primary care providers and psychotherapists, engaging in psychoeducation with patients, to prescribing via telemedicine. Readers will pick up the foundational knowledge they need to develop a partnership with patients that is based on trust and candid communication-rather than on just the cold facts about psychotropic medications. Chapters feature key takeaways that distill the most salient points, helping readers to reference-and retain-the information easily"--
Contributors ix
Uncovered xvii
Prescriber, Prescribe Thyself (By Way of Introduction) xix
Andres Martin
Shashank V. Joshi
Part I Principles
1 Think Again About Prescribing: The Psychology of Psychopharmacology
3(22)
Kyle D. Pruett
2 The Many Facets of Alliance: The Y-Model Applied to Child, Adolescent, and Young Adult Pharmacotherapy
25(20)
Magdalena Romanowicz
Sarah Rosenbaum
Carl Feinstein
3 Psychodynamics of Medication Use in Youth With Serious Mental Illness
45(14)
Barri Belnap
Erin Seery
John Azer
David Mintz
4 "What's in It for Me?": Adapting Evidence-Based Motivational Interviewing and Therapy Techniques to Adolescent Psychiatry
59(20)
John J. DiLallo
5 Providing Psychoeducation in Pharmacotherapy
79(22)
Srinivasa B. Gokarakonda
Peter S. Jensen
Part II Partners
6 #KeepltReal: The Myth of the "Med Check" and the Realities of the Time-Limited Pharmacotherapy Visit
101(18)
Max S. Rosen
Anne L. Glowinski
7 Pharmacotherapy or Psychopharmacotherapy: When Therapist and Pharmacologist Are Different People--or the Same Person
119(18)
Mari Kurahashi
Elizabeth Reichert
Nithya Mani
David S. Hong
8 The Pharmacotherapeutic Role of the Pediatrician, Advanced Practice Clinician, and Other Primary Care Providers
137(20)
Katherine M. Ort
Amy Heneghan
Part III Settings
9 The Pharmacotherapeutic Alliance in School Mental Health
157(20)
Andrew Connor
Shashank V. Joshi
10 When Time Is Tight and Stakes Are High: Pharmacotherapy, Alliances, and the Inpatient Unit
177(18)
Andrea Tabuenca
Jung Won Kim
Shih Yee-Marie Tan Gipson
11 Telepsychiatry Goes Viral: Psychotherapeutic Aspects of Prescribing Via Telemedicine Amid (and After) COVID-19
195(20)
Jeff Q. Bostic
Sean Pustilnik
David Kaye
Part IV Populations
12 Alliance Issues to Consider in Pharmacotherapy With Transition-Age Youth
215(16)
Jennifer Derenne
Farrah Fang
Anthony L. Rostain
13 The Pharmacotherapeutic Alliance When Working With Diverse Youth and Families
231(12)
Takesha Cooper
Michelle Tom
Erin Fletcher
14 The Psychopharmacotherapeutic Alliance When Resources Are Limited
243(18)
Arthur Caye
Brandon A. Kohrt
Christian Kieling
Part V Research
15 Building a Therapeutic Alliance in Psychopharmacology During Clinical Trials: Ethical and Practical Considerations
261(26)
Manpreet K. Singh
Janice Cho
16 The Power of Placebo
287(22)
Jeffrey R. Strawn
Jeffrey A. Mills
Tara S. Paris
John T. Walkup
Part VI Becoming
7 The "Good Enough" Pediatric Psychopharmacotherapist: Practical Pointers in Six Parables
309(10)
Ian Tofler
18 Teaching and Mentoring the Next Generation of Pediatric Psychopharmacotherapists
319(22)
Dorothy Stubbe
Isheeta Zalpuri
Mandeep Kaur Kapur
Donald M. Hilty
Gratitude 341(6)
Shashank V. Joshi
Index 347
Shashank V. Joshi, M.D., is Professor of Psychiatry, Pediatrics, and Education at the Stanford University School of Medicine and Graduate School of Education, Director of School Mental Health at Lucile Packard Children's Hospital, and a Faculty Advisor at the Center for Comparative Studies in Race and Ethnicity (CCSRE), in Stanford, California.





Andrés Martin, M.D., M.P.H., is the Riva Ariella Ritvo Professor, Child Study Center, Yale School of Medicine, in New Haven, Connecticut. He is Medical Director of the Children's Psychiatric Inpatient Service at Yale New Haven Health, in New Haven, Connecticut.